Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fulgent Genetics Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
FLGT
Nasdaq
3845
https://www.fulgentgenetics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fulgent Genetics Inc
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
- May 4th, 2024 1:15 pm
Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
- May 4th, 2024 7:04 am
Q1 2024 Fulgent Genetics Inc Earnings Call
- May 4th, 2024 2:46 am
Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses
- May 3rd, 2024 12:34 pm
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
- May 3rd, 2024 12:15 pm
Fulgent Reports First Quarter 2024 Financial Results
- May 3rd, 2024 11:00 am
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
- Apr 11th, 2024 8:05 pm
Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years
- Apr 11th, 2024 12:44 pm
An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued
- Mar 1st, 2024 11:19 am
Fulgent Genetics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
- Mar 1st, 2024 10:48 am
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 2:31 pm
Q4 2023 Fulgent Genetics Inc Earnings Call
- Feb 29th, 2024 3:18 am
Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023
- Feb 28th, 2024 12:35 pm
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 28th, 2024 12:00 pm
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
- Feb 13th, 2024 1:00 pm
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
- Feb 9th, 2024 1:31 pm
The 3 Best Digital Health Stocks for Personalized Medicine
- Nov 25th, 2023 2:45 pm
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
- Nov 14th, 2023 9:30 pm
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript
- Nov 5th, 2023 2:02 pm
Q3 2023 Fulgent Genetics Inc Earnings Call
- Nov 4th, 2023 2:26 am
Scroll